Patrick Fivey

Director of Precision Medicine Policy
AstraZeneca, United Kingdom

Patrick is currently the Director of Precision Medicine Policy at AstraZeneca R&D and is also a precision medicine representative at 3 industry trade bodies (EFPIA, ABPI, iPWG) in their regulatory impact work streams. Patrick has worked in the pharmaceutical industry for the last 29 years, with 17 of these focused upon oncology precision medicines. In the last 4 years, his focus has been upon the changing European regulatory environment for companion diagnostics and IVDs and the impact upon precision medicine development. He holds a degree in Molecular Biology and a MBA, in addition to a post graduate certificate in health economics.

Disclosure information not submitted.

Presentation(s):

• CDx or Not CDx, That is The Question - The Impact of the Clinical Trial Regulation on Tests Used in Pharma Studies and Whether and How the IVDR Applies

  Thursday, May 11, 2023
  13:45 – 14:45 CEST